| Literature DB >> 30804461 |
Swaib A Lule1,2, Benigna Namara3, Helen Akurut3, Lawrence Lubyayi3, Margaret Nampijja3, Florence Akello3, Josephine Tumusiime3, Judith C Aujo4, Gloria Oduru3, Alexander J Mentzer5, Liam Smeeth6, Alison M Elliott6,3, Emily L Webb6.
Abstract
We aimed to investigate life-course factors associated with blood pressure (BP) among Ugandan adolescents. Between 9th April 2003 and 24th November 2005, 2507 pregnant women from Entebbe municipality and Katabi sub-county were enrolled into a deworming trial. The resulting 2345 live-born offspring were followed to age 10 or 11 years, when between 20th May 2014 to 16th June 2016, BP was measured following standard protocols. Factors associated with BP were assessed using multivariable linear regression. BP was measured in 1119 adolescents with a median age of 10.2 years. Mean systolic BP and diastolic BP was 105.9 mmHg (standard deviation (SD) 8.2) and 65.2 mmHg (SD 7.3), respectively. Maternal gestational body mass index (BMI), higher maternal education status and family history of hypertension were positively associated with adolescent BP. Childhood (age ≤5 years) malaria was associated with lower adolescent systolic BP. Factors measured at time of BP measurement positively associated with systolic BP were age, BMI, waist circumference and Trichuris trichiura (whipworm) infection; higher vegetable consumption was associated with lower systolic BP. Results for diastolic BP were similar, except higher fruit, rather than higher vegetable consumption was associated with lower diastolic BP and there was no association with waist circumference or Trichuris trichiura infection. In summary, life-course exposures were associated with adolescent BP in this tropical birth cohort. Malaria early in life could impact later BP. Interventions initiated early in life targeting individuals with family history of hypertension, aiming to reduce adiposity (in pregnancy and adolescence) and promoting fruit and vegetable consumption might contribute to reducing the risk of high BP and subsequent cardiovascular diseases.Entities:
Mesh:
Year: 2019 PMID: 30804461 PMCID: PMC6760975 DOI: 10.1038/s41371-019-0178-y
Source DB: PubMed Journal: J Hum Hypertens ISSN: 0950-9240 Impact factor: 3.012
Fig. 1Conceptual framework
Factors investigated for association with systolic blood pressure among adolescents from the Entebbe Mother and Baby Study (N = 1119)
| Factors | Mean BP (SD) | Crude | Adjusted | |||
|---|---|---|---|---|---|---|
| Level 1: Maternal factors at enrolments | ||||||
| Age (years) | 0.06 (−0.03, 0.15) | 0.178 | 0.02 (−0.07, 0.12) | 0.604 | ||
| Household socioeconomic index ( | 0.23 (−0.16, 0.63) | 0.245 | ||||
| Parity | 0.04 (−0.23, 0.31) | 0.751 | ||||
| Body mass index (kg/m2) ( | 0.27 (0.13, 0.42) | <0.001 |
|
| ||
| Education status | ||||||
| None ( | 104.5 (8.7) | −0.54 (−3.65, 2.56) |
| |||
| Primary ( | 105.0 (7.7) | Reference |
| |||
| Senior ( | 106.5 (8.2) | 1.45 (0.42, 2.48) |
| |||
| Tertiary ( | 108.2 (9.8) | 3.19 (1.51, 4.87) | <0.001 |
|
| |
| Marital status | ||||||
| Single ( | 104.7 (7.6) | −1.34 (−2.92, 0.25) | ||||
| Married/cohabiting ( | 106.0 (8.3) | Reference | ||||
| Separated/widowed ( | 105.3 (6.1) | −0.78 (−3.56, 1.99) | 0.229 | |||
| Area of residence | ||||||
| Urban ( | 106.0 (8.3) | Reference | ||||
| Rural ( | 105.5 (8.0) | −0.47 (−1.52, 0.59) | 0.386 | |||
| Alcohol use | ||||||
| No ( | 105.8 (8.4) | Reference | ||||
| Yes ( | 106.0 (7.8) | 0.15 (−0.90, 1.19) | 0.781 | |||
| Infections | ||||||
| HIV | ||||||
| Uninfected ( | 106.0 (8.3) | Reference | Reference | |||
| Infected ( | 104.8 (7.2) | −1.17 (−2.74, 0.41) | 0.146 | −0.88 (−2.48, 0.72) | 0.279 | |
| Asymptomatic malaria | ||||||
| Uninfected ( | 105.8 (8.2) | Reference | ||||
| Infected ( | 106.2 (8.6) | 0.42 (−1.20, 2.05) | 0.609 | |||
| | ||||||
| Uninfected ( | 105.8 (8.3) | Reference | ||||
| Infected ( | 106.2 (7.9) | 0.35 (−0.90, 1.61) | 0.578 | |||
| Hookworm ( | ||||||
| Uninfected ( | 105.8 (8.1) | Reference | ||||
| Infected ( | 105.9 (8.4) | 0.10 (−0.89, 1.09) | 0.844 | |||
| | ||||||
| Uninfected ( | 105.9 (8.3) | Reference | ||||
| Infected ( | 105.7 (6.7) | −0.17 (−3.27, 2.92) | 0.912 | |||
| Intervention one | ||||||
| Placebo ( | 105.5 (8.2) | Reference | Reference | |||
| Albendazole ( | 106.2 (8.3) | 0.67 (−0.29, 1.63) | 0.173 | 0.84 (−0.12, 1.80) | 0.087 | |
| Intervention two | ||||||
| Placebo ( | 106.0 (8.1) | Reference | ||||
| Praziquantel ( | 105.8 (8.4) | −0.20 (−1.16, 0.77) | 0.686 | |||
| Level 2: Factors in childhood | ||||||
| Birth weight (kg) ( | 0.73 (−0.33, 1.80) | 0.178 | 0.18 (−0.93, 1.29) | 0.751 | ||
| Sex | ||||||
| Male ( | 105.9 (7.5) | Reference | Reference | |||
| Female ( | 105.9 (9.0) | −0.02 (−0.98, 0.95) | 0.971 | 0.12 (−1.18, 0.94) | 0.819 | |
| Sickle-cell trait | ||||||
| HbAA ( | 106.0 (8.4) | Reference | ||||
| HbAS ( | 105.8 (7.9) | −0.28 (−1.79, 1.23) | 0.717 | |||
| Season of birth | ||||||
| Dry ( | 106.1 (8.1) | Reference | ||||
| Wet ( | 105.5 (8.3) | −0.56 (−1.54, 0.42) | 0.261 | |||
| Place of delivery | ||||||
| Entebbe Hospital ( | 105.8 (8.2) | Reference | Reference | |||
| Home ( | 104.9 (8.6) | −0.86 (−2.43, 0.71) | −0.37 (−3.71, 2.96) | |||
| Others ( | 106.8 (8.0) | 0.95 (−0.39, 2.29) | 0.166 | 0.90 (−0.87, 2.68) | 0.582 | |
| Feeding status (at 6 weeks of age) | ||||||
| Exclusively breast fed ( | 106.1 (8.2) | Reference | ||||
| Mixed fed ( | 105.4 (8.4) | −0.70 (−1.75, 0.35) | ||||
| Weaned ( | 105.8 (7.1) | −0.28 (−4.63, 4.08) | 0.430 | |||
| Intervention three | ||||||
| Placebo ( | 105.5 (8.4) | Reference | ||||
| Albendazole ( | 106.1 (8.0) | 0.61 (−0.36, 1.58) | 0.218 | |||
| HIV status | ||||||
| Unexposed ( | 106.0 (8.3) | Reference | Reference | |||
| Exposed not infected ( | 105.2 (7.3) | −0.83 (−2.52, 0.86) | −0.29 (−2.15, 1.57) | |||
| Infected ( | 102.7 (6.1) | −3.34 (−7.17, 0.49) | 0.156 | −3.85 (−7.81, 0.12) | 0.157 | |
| Malaria infection below 5 years of age | ||||||
| Clinical or asymptomatica | ||||||
| None ( | 106.6 (8.0) | Reference |
| |||
| Yes ( | 105.3 (8.3) | −1.31 (−2.29, −0.33) | 0.009 |
|
| |
| Clinical malariaa | ||||||
| None ( | 106.6 (8.0) | Reference |
| |||
| Yes ( | 105.4 (8.3) | −1.19 (−2.17, −0.22) | 0.016 |
|
| |
| Episodes of clinical malariaa | ||||||
| None ( | 106.6 (8.0) | Reference | Reference | |||
| 1–2 ( | 105.4 (8.4) | −1.13 (−2.24, −0.03) | −1.11 (−2.32, 0.11) | |||
| ≥3 ( | 105.3 (8.2) | −1.28 (−2.52, −0.04) | 0.026 [trend] | −1.05 (−2.41, 0.31) | 0.133 | |
| Asymptomatic malariaa | ||||||
| None ( | 106.1 (8.2) | Reference |
| |||
| Yes ( | 103.7 (8.0) | −2.41 (−3.94, −0.88) | 0.002 |
|
| |
| | ||||||
| Uninfected ( | 105.9 (8.2) | Reference | ||||
| Infected ( | 104.8 (7.9) | −1.09 (−3.94, 1.76) | 0.452 | |||
| | ||||||
| Uninfected ( | 105.9 (8.3) | Reference | ||||
| Infected ( | 105.3 (7.3) | −0.62 (−2.82, 1.57) | 0.576 | |||
| Hookworm ( | ||||||
| Uninfected ( | 105.9 (8.2) | Reference | ||||
| Infected ( | 103.8 (8.9) | −2.06 (−5.38, 1.27) | 0.225 | |||
| | ||||||
| Uninfected ( | 105.9 (8.2) | Reference | ||||
| Infected ( | 105.6 (8.6) | −0.28 (−1.89, 1.33) | 0.731 | |||
| Microfilaria ( | ||||||
| Uninfected ( | 105.8 (8.2) | Reference | ||||
| Infected ( | 109.4 (8.9) | 3.58 (−2.13, 9.28) | 0.219 | |||
| Level 3: Factors in adolescence | ||||||
| Age (years) | 2.12 (1.17, 3.08) | <0.001 |
|
| ||
| Body mass index (kg/m2) | 1.27 (1.02, 1.51) | <0.001 |
|
| ||
| Waist circumference (cm) | 0.46 (0.36, 0.55) | <0.001 |
|
| ||
| Family history | ||||||
| High blood pressure | ||||||
| No ( | 105.7 (8.1) | Reference |
| |||
| Yes ( | 107.6 (8.3) | 1.88 (0.24, 3.52) | 0.025 |
|
| |
| Diabetes | ||||||
| No ( | 105.8 (8.0) | Reference | ||||
| Yes ( | 106.4 (9.2) | 0.69 (−0.61, 1.99) | 0.296 | |||
| Body composition analysisc | ||||||
| Fat mass indexb (kg/m2) ( | 3.27 (2.29, 4.24) | <0.001 | 1.50 (−0.38, 3.38) | 0.089 | ||
| Fat-free mass indexb (kg/m2) ( | 1.54 (0.65, 2.43) | 0.001 | −0.86 (−2.25, 0.54) | 0.188 | ||
| Total body water indexb (kg/m2) ( | 4.20 (2.97, 5.42) | <0.001 | 2.51 (−0.24, 5.27) | 0.052 | ||
| Adding salt to cooked food at the table | ||||||
| No ( | 106.2 (7.3) | 0.36 (−3.28, 4.00) | ||||
| Yes ( | 105.9 (8.2) | Reference | 0.846 | |||
| Days a fruit is eaten/week | ||||||
| 0–2 ( | 106.3 (8.0) | Reference | Reference | |||
| 3–7 ( | 105.5 (8.5) | −0.83 (−1.82, 0.15) | 0.098 | −0.83 (−1.84, 0.19) | 0.106 | |
| Days vegetables eaten/week | ||||||
| 0–2 ( | 106.4 (8.2) | Reference |
| |||
| 3–7 ( | 105.5 (8.3) | −0.94 (−1.93, 0.05) | 0.063 |
|
| |
| Days animal-protein eaten/week | ||||||
| 0–2 ( | 105.4 (7.8) | Reference | Reference | |||
| 3–7 ( | 106.6 (8.8) | 1.17 (0.16, 2.19) | 0.024 | 0.99 (−0.06, 2.04) | 0.062 | |
| Days sugared drinks taken/week | ||||||
| None ( | 105.4 (8.1) | Reference | Reference | |||
| 1–3 ( | 105.9 (8.0) | 0.54 (−0.53, 1.61) | −0.05 (−1.14, 1.05) | |||
| 4–7 ( | 107.2 (9.1) | 1.81 (0.36, 3.26) | 0.051 | 0.96 (−0.53, 2.44) | 0.358 | |
| Days a fruit is eaten/week | −0.05 (−0.27, 0.18) | 0.687 | ||||
| Days vegetables eaten/week | −0.18 (−0.39, 0.03) | 0.085 | −0.19 (−0.40, 0.03) | 0.081 | ||
| Days animal-protein eaten/week | 0.21 (−0.07, 0.50) | 0.138 | 0.10 (−0.20, 0.39) | 0.502 | ||
| Days starchy foods eaten/week | 0.14 (−0.45, 0.73) | 0.636 | ||||
| Days sugared drinks taken/week | 0.23 (0.00, 0.46) | 0.049 | 0.11 (−0.12, 0.35) | 0.325 | ||
| Breast development (girls only)b | ||||||
| Pre-pubertal ( | 103.9 (7.8) | Reference | Reference | |||
| Pubertal ( | 108.0 (10.5) | 4.07 (1.87, 6.26) | <0.001 | 1.17 (−1.26, 3.59) | 0.318 | |
| Pubic hair developmentb | ||||||
| Pre-pubertal ( | 104.7 (7.4) | Reference | Reference | |||
| Pubertal ( | 106.5 (9.3) | 1.83 (0.42, 3.24) | 0.011 | 0.51 (−0.96, 1.98) | 0.486 | |
| Snoring | ||||||
| No ( | 105.8 (8.2) | Reference | ||||
| Yes ( | 106.3 (8.2) | 0.53 (−0.83, 1.90) | 0.444 | |||
| Duration of night sleep | ||||||
| <9 hours ( | 106.1 (8.0) | Reference | ||||
| 9 hours ( | 105.8 (8.8) | −0.28 (−1.51, 0.96) | ||||
| >9 hours ( | 105.7 (7.7) | −0.39 (−1.61, 0.83) | 0.818 | |||
| Smoking in household | ||||||
| No ( | 106.0 (8.3) | Reference | Reference | |||
| Yes ( | 104.9 (7.5) | −1.03 (−2.46, 0.40) | 0.157 | −0.65 (−2.10, 0.80) | 0.372 | |
| Type of school attended | ||||||
| Day ( | 105.7 (7.9) | Reference | Reference | |||
| Boarding school ( | 107.5 (10.3) | 1.76 (0.19, 3.34) | 0.038 | 0.28 (−1.38, 1.95) | 0.733 | |
| Involved in physical education at school | ||||||
| No ( | 105.5 (8.5) | Reference | ||||
| Yes ( | 106.0 (8.1) | 0.48 (−0.54, 1.50) | 0.360 | |||
| Infections at the time of blood pressure measurement | ||||||
| Asymptomatic malaria | ||||||
| Uninfected ( | 106.0 (8.2) | Reference | Reference | |||
| Infected ( | 103.1 (9.3) | −2.85 (−6.31, 0.61) | 0.106 | −1.50 (−5.02, 2.02) | 0.397 | |
| | ||||||
| Uninfected ( | 105.9 (8.3) | Reference | ||||
| Infected ( | 105.7 (8.4) | −0.25 (1.88, 1.38) | 0.764 | |||
| Hookworm ( | ||||||
| Uninfected ( | 105.9 (8.3) | Reference | ||||
| Infected ( | 103.8 (10.0) | −2.10 (−7.27, 3.07) | 0.425 | |||
| Ascaris ( | ||||||
| Uninfected ( | 105.9 (8.3) | Reference | Reference | |||
| Infected ( | 98.7 (1.6) | −7.34 (−16.65, 2.17) | 0.132 | −7.04 (−15.97, 1.88) | 0.117 | |
| | ||||||
| Uninfected ( | 105.8 (8.3) | Reference |
| |||
| Infected ( | 107.9 (8.3) | 2.16 (−0.46, 4.78) | 0.106 |
|
| |
Model building followed the hierarchical approach, adding factors sequentially at three levels starting with the distal factors (level 1). Factors at the same level were added to the model at the same time and considered confounders for each other and for proximal factors. A P-value < 0.20 was used for considering the inclusions and maintenance of factors in the model
Adjusted β with 95% CI excluding 0 in bold
β linear regression coefficient: mean difference in blood pressure (BP) measured in mmHg
aNot included in the model together but each was adjusted for all other model variables
bNot included in multivariable model building for other exposures because of large proportion of missing information but each was adjusted for variables in the final model building
cNot adjusted for body mass index because body mass index is on the causal pathway
Factors investigated for association with diastolic blood pressure among adolescents from the Entebbe Mother and Baby Study (N = 1119)
| Mean BP (SD) | Crude | Adjusted | |||
|---|---|---|---|---|---|
| Level 1: Maternal factors | |||||
| Age (years) | 0.08 (−0.00, 0.15) | 0.058 | 0.05 (−0.03, 0.13) | 0.247 | |
| Household socioeconomic index ( | 0.22 (−0.13, 0.56) | 0.225 | |||
| Parity | 0.08 (−0.16, 0.32) | 0.530 | |||
| Body mass index ( | 0.16 (0.03, 0.29) | 0.014 |
|
| |
| Education status | |||||
| None ( | 65.1 (9.3) | 0.44 (−2.32, 3.19) |
| ||
| Primary ( | 64.6 (6.7) | Reference |
| ||
| Senior ( | 65.5 (7.5) | 0.92 (0.01, 1.84) |
| ||
| Tertiary ( | 66.8 (8.0) | 2.14 (0.65, 3.64) | 0.023 |
|
|
| Marital status | |||||
| Single ( | 64.2 (6.4) | −1.19 (−2.59, 0.21) | −1.26 (−2.69, 0.16) | ||
| Married/cohabiting ( | 65.4 (7.4) | Reference | Reference | ||
| Separated/widowed ( | 63.5 (6.0) | −1.91 (−4.36, 0.54) | 0.089 | −1.91 (−4.38, 0.54) | 0.075 |
| Area of residence | |||||
| Urban ( | 65.3 (7.5) | Reference | |||
| Rural ( | 64.9 (6.8) | 0.49 (−1.42, 0.44) | 0.302 | ||
| Alcohol use | |||||
| No ( | 65.3 (7.5) | Reference | |||
| Yes ( | 65.0 (6.6) | −0.34 (−1.26, 0.59) | 0.477 | ||
| Infections | |||||
| HIV | |||||
| Uninfected ( | 65.2 (7.3) | Reference | |||
| Infected ( | 64.9 (6.5) | −0.35 (−1.74, 1.05) | 0.626 | ||
| Asymptomatic malaria | |||||
| Uninfected ( | 65.2 (7.4) | Reference | |||
| Infected ( | 64.9 (6.6) | −0.29 (−1.73, 1.15) | 0.695 | ||
| | |||||
| Uninfected ( | 65.2 (7.1) | Reference | |||
| Infected ( | 65.5 (7.7) | 0.31 (−0.79, 1.41) | 0.579 | ||
| Hookworm ( | |||||
| Uninfected ( | 65.1 (7.1) | Reference | |||
| Infected ( | 65.4 (7.4) | 0.27 (−0.60, 1.14) | 0.539 | ||
| | |||||
| Uninfected ( | 65.3 (7.3) | Reference | |||
| Infected ( | 65.1 (5.5) | −0.18 (−2.90, 2.54) | 0.896 | ||
| Intervention one | |||||
| Placebo ( | 65.0 (6.9) | Reference | |||
| Albendazole ( | 65.4 (7.7) | 0.39 (−0.46, 1.24) | 0.366 | ||
| Intervention two | |||||
| Placebo ( | 65.4 (7.3) | Reference | |||
| Praziquantel ( | 65.0 (7.2) | −0.44 (−1.29, 0.42) | 0.315 | ||
| Level 2: Factors in childhood | |||||
| Birth weight (kg) ( | 0.66 (−0.27, 1.59) | 0.164 | 0.57 (−0.40, 1.53) | 0.246 | |
| Sex | |||||
| Male ( | 64.9 (7.2) | Reference | Reference | ||
| Female ( | 65.5 (7.4) | 0.64 (−0.21, 1.49) | 0.141 | 0.49 (−0.43, 1.42) | 0.294 |
| Sickle-cell trait | |||||
| HbAA ( | 65.4 (7.1) | Reference | |||
| HbAS ( | 65.5 (7.4) | 0.15 (−1.16, 1.46) | 0.825 | ||
| Season of birth | |||||
| Dry ( | 65.5 (7.3) | Reference | Reference | ||
| Wet ( | 64.7 (7.2) | −0.79 (−1.65, 0.07) | 0.073 | 0.59 (−1.52, 0.35) | 0.214 |
| Place of delivery | |||||
| Entebbe Hospital ( | 65.1 (7.1) | Reference | |||
| Home ( | 65.4 (8.5) | 0.36 (−1.03, 1.76) | |||
| Others ( | 65.7 (7.3) | 0.61 (−0.58, 1.80) | 0.564 | ||
| Feeding status (at 6 week of age) | |||||
| Exclusive breast fed ( | 65.4 (7.4) | Reference | |||
| Mixed fed ( | 64.7 (7.0) | −0.63 (−1.56, 0.30) | |||
| Weaned ( | 67.1 (4.4) | 1.78 (−2.07, 5.63) | 0.251 | ||
| Intervention three | |||||
| Placebo ( | 64.9 (7.0) | Reference | Reference | ||
| Albendazole ( | 65.5 (7.5) | 0.62 (−0.24, 1.47) | 0.156 | 0.56 (−0.37, 1.48) | 0.233 |
| HIV status | |||||
| Unexposed ( | 65.2 (7.3) | Reference | |||
| Exposed not infected ( | 65.1 (6.7) | −0.12 (−1.62, 1.37) | |||
| Infected ( | 63.5 (5.1) | −1.71 (−5.10, 1.68) | 0.609 | ||
| Malaria infection below 5 years of age | |||||
| Clinical or asymptomatic malariaa | |||||
| No ( | 65.9(7.1) | Reference |
| ||
| Yes ( | 64.6 (7.3) | −1.28 (−2.14, −0.41) | 0.004 |
|
|
| Clinical malariaa | |||||
| None ( | 66.0 (7.2) | Reference |
| ||
| Yes ( | 64.6 (7.3) | −1.38 (−2.24, −0.51) | 0.002 |
|
|
| Episodes of clinical malariaa | |||||
| None ( | 65.9 (7.2) | Reference |
| ||
| 1–2 ( | 64.5 (7.3) | −1.45 (−2.42, −0.47) |
| ||
| ≥3 ( | 64.9 (7.4) | −1.02 (−2.12, 0.07) | 0.011 |
|
|
| Asymptomatic malariaa | |||||
| None ( | 64.5 (7.3) | Reference | Reference | ||
| Yes ( | 64.9 (7.4) | −1.45 (−2.80, −0.10) | 0.035 | −1.35 (−2.89, 0.18) | 0.082 |
| | |||||
| Uninfected ( | 65.2 (7.3) | Reference | |||
| Infected ( | 64.5 (5.8) | 0.67 (−3.18, 1.84) | 0.602 | ||
| | |||||
| Uninfected ( | 65.2 (7.3) | Reference | |||
| Infected ( | 64.5 (7.1) | −0.75 (−2.68, 1.18) | 0.445 | ||
| Hookworm ( | |||||
| Uninfected ( | 65.2 (7.3) | Reference | Reference | ||
| Infected ( | 62.9 (5.8) | −2.29 (−5.22, 0.64) | 0.125 | −1.79 (−4.93, 1.35) | 0.261 |
| | |||||
| Uninfected ( | 65.1 (7.2) | Reference | |||
| Infected ( | 65.8 (7.7) | 0.67 (−0.74, 2.09) | 0.353 | ||
| Microfilaria ( | |||||
| Uninfected ( | 65.1 (7.2) | Reference | |||
| Infected ( | 67.3 (3.3) | 2.12 (−2.91, 7.14) | 0.409 | ||
| Level 3: Factors in adolescence | |||||
| Age (years) | 1.85(1.00, 2.70) | <0.001 |
|
| |
| Body mass index (kg/m2) | 0.28 (0.20, 0.36) | <0.001 |
|
| |
| Waist circumference (cm) | 0.88 (0.66, 1.10) | <0.001 | 0.07 (−0.05, 0.18) | 0.279 | |
| Family history | |||||
| High blood pressure | |||||
| No ( | 65.0 (7.2) | Reference |
| ||
| Yes ( | 66.7 (7.6) | 1.65 (0.19, 3.12) | 0.027 |
|
|
| Diabetes | |||||
| No ( | 65.2 (7.2) | Reference | |||
| Yes ( | 65.5 (7.8) | 0.35 (−0.80, 1.49) | 0.553 | ||
| Body composition analysisc | |||||
| Fat mass indexb (kg/m2) ( | 1.75 (0.83, 2.69) | <0.001 | 0.87 (−0.73, 2.47) | 0.255 | |
| Fat-free mass indexb (kg/m2) ( | 1.19 (0.40, 1.98) | 0.003 | 0.28 (−0.90, 1.45) | 0.622 | |
| Total body water indexb (kg/m2) ( | 2.13 (0.95, 3.30) | <0.001 | 1.51 (−0.86, 3.88) | 0.180 | |
| Adding salt to cooked food at the table | |||||
| No ( | 67.4 (6.1) | 2.19 (−1.04, 5.41) | 2.72 (−0.39, 5.82) | ||
| Yes ( | 65.2 (7.3) | Reference | 0.184 | Reference | 0.083 |
| Days a fruit is eaten/week | |||||
| 0–2 ( | 65.7 (7.1) | Reference |
| ||
| 3–7 ( | 64.7 (7.5) | −0.98 (−1.85, −0.11) | 0.028 |
|
|
| Days vegetables eaten/week | |||||
| 0–2 ( | 65.4 (7.1) | Reference | |||
| 3–7 ( | 65.1 (7.5) | −0.27 (−1.15, 0.60) | 0.540 | ||
| Days animal-protein eaten/week | |||||
| 0–2 ( | 65.1 (6.9) | Reference | |||
| 3–7 ( | 65.4 (8.0) | 0.30 (−0.61, 1.20) | 0.523 | ||
| Days sugared drinks taken/week | |||||
| None ( | 65.0 (7.1) | Reference | Reference | ||
| 1–3 ( | 65.2 (7.4) | 0.25 (−0.70, 1.20) | 0.12 (−0.84, 1.08) | ||
| 4–7 ( | 66.0 (7.5) | 1.06 (−0.23, 2.35) | 0.271 | 0.54 (−0.75, 1.83) | 0.707 |
| Days a fruit is eaten/week | |||||
| Days vegetables eaten/week | 0.02 (−0.16, 0.1) | 0.800 | |||
| Days animal-protein eaten/week | 0.14 (−0.11, 0.39) | 0.284 | |||
| Days starchy foods eaten/week | 0.03 (−0.50, 0.55) | 0.924 | |||
| Days sugared drinks taken/week | 0.20 (0.00, 0.41) | 0.048 | |||
| Breast development (girls only)b | |||||
| Pre-pubertal ( | 64.1 (6.1) | Reference | Reference | ||
| Pubertal ( | 67.2 (7.9) | 3.067 (1.38, 4.76) | <0.001 | 0.98 (−0.88, 2.84) | 0.281 |
| Pubic hair developmentb | |||||
| Pre-pubertal ( | 64.1 (6.6) | Reference | Reference | ||
| Pubertal ( | 66.1 (7.6) | 2.04 (0.82, 3.26) | 0.001 | 0.68 (−0.62, 1.99) | 0.293 |
| Snoring | |||||
| No ( | 65.1 (7.2) | Reference | |||
| Yes ( | 65.6 (7.8) | 0.44 (−0.78, 1.66) | 0.477 | ||
| Duration of night sleep | |||||
| <9 hours ( | 65.8 (7.6) | Reference | Reference | ||
| 9 hours ( | 64.8 (7.1) | −1.03 (−2.11, 0.06) | −0.92 (−2.02, 0.18) | ||
| >9 hours ( | 65.2 (7.2) | −0.79(−1.86, 0.28) | 0.160 | −0.67 (−1.76, 0.43) | 0.240 |
| Smoking in household | |||||
| Non ( | 65.2 (7.3) | Reference | |||
| Yes ( | 65.0 (6.8) | −0.21 (−1.46, 1.06) | 0.745 | ||
| Type of school attended | |||||
| Day ( | 65.1 (7.2) | Reference | Reference | ||
| Boarding school ( | 66.2 (7.8) | 1.13 (−0.26, 2.52) | 0.112 | −0.24 (−1.67, 1.20) | 0.737 |
| Involved in physical education at school | |||||
| No ( | 65.0 (6.9) | Reference | |||
| Yes ( | 65.3 (7.5) | 0.32 (−0.58, 1.22) | 0.482 | ||
| Infections at the time of blood pressure measurement | |||||
| Asymptomatic malaria | |||||
| Uninfected ( | 65.3 (7.3) | Reference | |||
| Infected ( | 64.0 (5.5) | −1.31 (−4.36, 1.75) | 0.401 | ||
| | |||||
| Uninfected ( | 65.2 (7.4) | Reference | |||
| Infected ( | 65.0 (5.8) | −0.19 (−1.62, 1.24) | 0.791 | ||
| Hookworm ( | |||||
| Uninfected ( | 65.2 (7.3) | Reference | |||
| Infected ( | 64.0 (5.9) | −1.25 (−5.80, 3.30) | 0.590 | ||
| Ascaris ( | |||||
| Uninfected ( | 65.2 (7.3) | Reference | |||
| Infected ( | 62.3 (4.3) | −2.86 (−11.14, 5.42) | 0.498 | ||
| | |||||
| Uninfected ( | 65.1 (7.2) | Reference | |||
| Infected ( | 66.4 (9.4) | 1.23 (−1.07, 3.54) | 0.294 |
Model building followed the hierarchical approach, adding factors sequentially at three levels starting with the distal factors (level 1). Factors at the same level were added to the model at the same time and considered confounders for each other and for proximal factors. A P-value < 0.20 was used for considering the inclusion and maintenance of factors in the model
Adjusted β for which 95% CI exclude 0 are highlighted in bold
β linear regression coefficient: mean difference in blood pressure (BP) measured in mmHg
aNot included in the model together but each was adjusted for all other variables in the model
bNot included in multivariable model building for other exposures because of large proportion of missing information; but each was adjusted for variables in the final model building
cNot adjusted for body mass index because body mass index is on the causal pathway